baber/WOPTO huggingface dataset:
Patent NZ-336095-A (NZ)
Title: Insecticidal and miticidal compositions containing 4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)pyrrole-3-carbonitrile ( chlorfenapyr )
Inventor: FUKUCHI TOSHIKI
IPC: A01N43/36
Filed: 1997-12-08
Abstract: An insecticidal and miticidal composition which contains 4-bromo-2-(4chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)- pyrrole-3-carbonitrile (chlorfenapyr) in combination with one or more compounds selected from the organophosphoric acid ester-type compounds represented by the general formulae (I) or (II),  wherein X represents an oxygen atom or sulfur atom, Y represents an oxygen atom or sulfur atom, group represented by -S(CH2)nS- (n is 1 or 2) or single bond, R1 represents C1-C6 alkyl group, R2 represents C1-C8 alkoxy group, C1-C8 alkyl- thio group, C1-C4 alkylcarbonylamino group, C1-C6 alkylamino group or phenyl group, and R3 represents C1-C8 alkyl group, C2-C6 alkenyl group, amino group, phenyl group, or heteroaryl group, which are optionally substituted by 1 to 4 same or different substituents selected from the substituent group A mentioned below, or formula (III)  Substituent group A consists of: C1-C8 alkyl group, C1-C8 alkoxy group, C1-C6 aliphatic acyl group, C1-C6 alkoxycarbonyl group, C1-C6 alkylthio group, C1-C6 alkylamino group, di-C1-C6 alkylamino group, C1-C4 alkylsulfinyl group, C1-C4 haloalkyl group, N-C1-C4 alkylcarbamoyl group, N,N-di-C1-C4 alkylcarbamoyl group, N-C1-C4 alkyl-N-formylcarbamoyl group, heteroaryl group which may be substituted, phenyl group which may be substituted, halogen atom, nitro group, cyano group, hydroxy group and acetylamino group.
Patent NZ-501766-A (NZ)
Title: Foldable strap to connect fence rail to post
Inventor: ROBB ERROL EDMOND
IPC: F16B7/04
Filed: 1999-12-14
Abstract: A connector (2) for joining a fence post (3) and a fence rail (4) formed from one piece of sheet material comprising two rail-engaging portions (5a, 5b) bent upon fixing to the shape of the outer surface of the fence rail (4) which clamps a channel shaped post engaging portion (6) to the fence post (3).
Patent NZ-502059-A (NZ)
Title: Method of treating benign prostatic hyperplasia using alpha-1-adrenoreceptor antagonist (alfuzosin, indoramin, terazosin, bunazosin, doxazosin, prazosin, tamsulosin, abanoquil)
Inventor: WYLLIE MICHAEL G
IPC: A61K/
Filed: 1997-03-26
Abstract: The use of drugs comprising a1-adrenoreceptor antagonists as medicaments to prevent or treat the formation of benign prostatic hyperplasia (BPH). a1-adrenoreceptor antagonists include compounds such as alfuzosin, indoramin, terazosin, bunazosin, doxazosin, prazosin, tamsulosin or abanoquil.
Patent NZ-502607-A (NZ)
Title: Branched polyolefin synthesis using an anionic initiator and at least one vinylic monomer
Inventor: WILCZEK LECH
IPC: C08F290/04
Filed: 1998-07-16
Abstract: A process for the anionic polymerization of at least one vinylic monomer to form a branched polymer, comprises: contacting, in the presence of an anionic initiator:  (i) one or more anionically polymerizable vinylic monomers having the formula CH2=CYZ, and (ii) an anionic polymerization chain terminating agent of formula CH2=CZ-Q-X wherein: Q is a covalent bond, R, C(O) or RC(O); Y is R, CO2R, CN or NR2; X is halogen or RSO3; Z is H, R or CN; and R is optionally substituted alkyl, olefin, aryl, aralkyl, alkaryl or organosilicon groups. The process produces high yields of the polymer having dense branch upon branch architecture and polymerizable vinylic chain termini, employing steps I, III, VI and at least one of II, IV and V: I. reacting (i) with an anionic initiator in a first step; II. decreasing the ratio of (i) to anionic initiator toward 1; III. adding (ii) optionally with some (i) in a second step; IV. selecting the rate of the (ii) addition, dependent on the reactivity of (ii); V. increasing the ratio of(ii) to anionic initiator toward 1; VI. increasing the conversion of (i), (ii) and olefinic end groups from 70 toward 100 %; and VII. optionally, converting anionic-growing end groups into non-polymerizable end groups. A polymer composition comprises the polymer of formula (I) having a branch-upon-branch structure and optionally a polymerizable olefinic end group: wherein: B having the formula (II); and B' = Y or B; m is 1-100, n is 0-50, p=0-100, n+m+p > 2; and if m > 1, then the m insertions are consecutive or not consecutive; W is CZ=CH2 or a non-polymerizable moiety; A is anionic initiator moiety R; and Q, Y, X, Z and R are as defined above.
Patent NZ-502628-A (NZ)
Title: N6-(epoxycycloalkyl) adenosine compounds and pharmaceuticals thereof; useful as A1 adenosine receptor agonists
Inventor: BELARDINELLI LUIZ
IPC: A61K31/52
Filed: 1996-12-26
Abstract: Use of an N6-(epoxycycloalkyl) adenosine compound of formula VIII, IX or X or a derivative thereof, and a pharmaceutically acceptable carrier, in the manufacture of a medicament for use as an A1 adenosine receptor agonist. Also described is the use of an N6-(epoxycycloalkyl) adenosine compound of formula VIII, IX or X or a derivative thereof, and a pharmaceutically acceptable carrier, in the manufacture of a medicament for use in slowing the A-V conduction in the heart.
Patent NZ-503552-A (NZ)
Title: Lower temperature (less than 800 degrees) vitreous bond for abrasive tools
Inventor: QI DONGXIN
IPC: B24D3/00
Filed: 1998-07-29
Abstract: The present invention provides a vitreous-bonded abrasive tool wherein the abrasive grit portion comprises a thermally sensitive abrasive grain, such as sintered sol gel microcrystalline alpha alumina abrasive grain or super-abrasive grain, and wherein the vitrified bond may be matured by firing at a temperature below about 875 DEG C. The invention further includes a novel vitrified bond composition.
Patent NZ-508762-A (NZ)
Title: Delavirdine tablet formulation
Inventor: LEE E JOHN
IPC: A61K47/02
Filed: 1999-06-07
Abstract: A non-sustained release pharmaceutical composition comprises 5 to 60% of a rapidly precipitating drug and least one of 2 to 25% of a binder and 6 to 40% of superdisintegrant. The drug is a relatively soluble salt or anhydrous form of a poorly soluble free acid or free base. Preferably the drug is delavirdine mesylate
Patent NZ-509877-A (NZ)
Title: Composition and administration of copper dextran for treating copper deficiency in animals
Inventor: LEECH WAYNE FREDERICK
IPC: A61P3/02
Filed: 2001-04-09
Abstract: A composition containing copper dextran in a form suitable for administration to a non-human animal to increase copper levels in the animal such that the level remains above 1000ìmol/kg after 14 days.  A method for increasing the copper levels in a non-human animal by the administration of a composition containing copper dextran in a dose in a manner such as parenterally, intramuscularly and a combination thereof.
Patent NZ-511896-A (NZ)
Title: A flexible conveyor belt and a climate chamber comprising a belt of that kind
Inventor: PERSSON SVEN
IPC: F25D13/06
Filed: 1999-11-17
Abstract: A  flexible  conveyor belt of the type  which  can  be assembled to form an endless loop, a part of which  forms  a number  of  layers stacked one on another. The belt  (3)  is constructed  from  mutually articulatable links  which  each comprise  at least two transverse rods (13) which,  at  each side  edge of the belt, bear support members (12) projecting upwardly  from the plane of the belt, which are intended  to support   a   belt  layer  lying  above.   The   links   are interconnected  so  that they can be displaced  relative  to one  another along at least one side edge of the  belt.  The support  members  (12) are connected  to  the  ends  of  the transverse   rods  (13)  in  the  belt  (3)  or   constitute extensions  of  these  rods  and comprise  a  stirrup-shaped support  portion which projects upwardly from the  plane  of the  belt  and interconnects the rods (13) in an  associated link  of the belt. There is also described a climate chamber comprising  a belt according to the above, and a method  for treating products in such a climate chamber.
Patent NZ-512826-A (NZ)
Title: Adjuvant composition
Inventor: BRIGANCE MICKEY R
IPC: A01N63/00
Filed: 2000-01-14
Abstract: A water soluble adjuvant composition for pesticide formulations is disclosed, which exhibits reduced eye irritancy is comprised of a polyoxyalkylene aliphatic amine containing at least about 2 moles of an alkylene oxide group and an eye irritation reducing compound which simultaneously reduces the eye irritation caused by the polyoxyalkylene aliphatic amine and which complexes with metal ions such as calcium and iron which may be present in an aqueous solution of the adjuvant and a pesticide or a plant growth regulator. The eye irritation reducing compound is a carboxylic add that is capable of complexing with or forming chelates with metal ions in aqueous solution while simultaneously reducing the eye irritation caused by the polyoxyalkylene aliphatic amine. The adjuvant also contains a mixture of polyhydric alcohols and, optionally, a defoamer. The adjuvant is particularly useful in N-phosphonomethylglycine (glyphosate) herbicidal formulations.
Patent NZ-514244-A (NZ)
Title: Laundry machine with an inclined frictionally engaged drum
Inventor: MYERSCOUGH MARTIN WILLIAM
IPC: D06F95/00
Filed: 2000-03-30
Abstract: A laundry machine, such as a washing machine, spin drier or tumble drier, including a drum (1) rotatably mounted about an axis, and including a generally open end (8) and a perforated container (3) arranged to be positioned within the drum (1) through the opening (8). A drum engaging surface (40. 40') is provided on the perforated container (3) for frictionally engaging the drum (1) such that the perforated container (3) is rotated with the drum (1). In a preferred example, the friction engaging surface is in the form of an elastic band (40) that is stretched around the outer surface of the perforated container (3), and which is located in a groove on the outer surface of the perforated container.
Patent NZ-514253-A (NZ)
Title: Process for producing ethanol
Inventor: VERSER DAN
IPC: C12P7/06
Filed: 2000-03-10
Abstract: A method of producing ethanol comprising fermentation of a medium containing a carbohydrate source into acetate, acetic acid and converting these to ethanol.  Carbohydrate source can be corn, wheat, wood waste paper, manure, cheese whey, molasses, sugar beets or sugar cane.  Fermentation is homoacetic or homolactic fermentation and is carried out via Clostridium or Lactobacillus respectively.
Patent NZ-516830-A (NZ)
Title: Humanized anti-ErbB2 antibodies conjugated with a cytotoxic or chemotherapeutic agent for treating cancer
Inventor: ADAMS CAMELLIA W
IPC: A61K33/243
Filed: 2000-06-23
Abstract: The present application describes the use of humanized anti-ErbB2 antibodies to treat cancer. The antibodies come in two containers wherein the first container contains a composition comprising a first antibody which binds ErbB2 and inhibits growth of cancer cells that overexpress ErbB2 and a second container containing a composition comprising a second antibody that binds ErbB2, blocks ligand activation of an ErbB2 receptor, and blocks binding of monoclonal antibody 2C4 to ErbB2.
Patent NZ-517919-A (NZ)
Title: Method for producing antibiotic composites including a plastic deformable antibiotic salt
Inventor: VOGT SEBASTIAN
IPC: A61K47/44
Filed: 2002-03-21
Abstract: A method for producing antibiotic composites is described, which is characterized in that a salt, which can be subjected to plastic deformation and which consists of at least one cationic component  of a protonated antibiotics base from the groups of aminoglycoside antibiotics, the lincosamide antibiotics and the tetracycline antibiotics and of at least one anionic components from the group of organic sulfates and/or organic sulfonates and/or fatty acid esters, is used as a binding agent for the fixation of inorganic composite components and/or possibly organic composite components and possibly for the molding of the composites while adding water, especially through pressing, extrusion, rolling, calendaring and grinding processes.
Patent NZ-518029-A (NZ)
Title: C-aryl glucoside SGLT2 inhibitors
Inventor: ELLSWORTH BRUCE
IPC: A61P17/02
Filed: 2000-10-02
Abstract: Disclosed are C-aryl glucoside compounds of formula (I), for which the substituents are defined herein. The compounds are used in the manufacture of SGLT2 inhibitor medicaments for use in treating disorders such as diabetes, obesity and Syndrome X.
Patent NZ-519147-A (NZ)
Title: Method for making hydrophobically associative polymers, methods of use and compositions
Inventor: ZHANG HUASHI
IPC: C09K23/02
Filed: 2000-12-05
Abstract: A method for producing a hydrophobically associative polymer comprising: (a) forming a monomer solution comprising surfactant, water, a hydrophobic ethylenically unsaturated monomer, a hydrophilic monomer selected from nonionic ethylenically monomers, cationic ethylenically unsaturated monomers, anionic ethylenically unsaturated monomers or mixtures thereof, (b) forming a salt solution comprising a multivalent salt, stabiliser and water, (c) mixing the monomer solution and salt solution to form a mixed solution, (d) charging the mixed solution with an initiator, thereby polymerisation the monomers to form the hydrophobically associative polymer in a dispersion. Also disclosed is an aqueous dispersion containing the hydrophobically associative polymer formed by the method. The aqueous dispersion containing the hydrophobically associative polymer may be used in a paint formulation, in a mobility control fluid useful in enhanced oil recovery, in a secondary or tertiary oil recovery system, in an enhanced oil recovery method, in a cementious composition, in an oil well drilling mud formulation, in a fracturing fluid formulation, in a wastewater treatment system, or in a dewatering sludge system.
Patent NZ-526799-A (NZ)
Title: Extracts from the marine algae undaria, compositions thereof and methods of use
Inventor: FITTON J HELEN
IPC: A61K31/715
Filed: 2003-07-01
Abstract: Use of an effective amount of a galactofucan sulfate from Undaria for the production of a pharmaceutical composition for the treatment, control and/or prophlyaxis of a viral infection in a human is disclosed. The specification discloses that galactofucan sulfate extracts from Undaria are successful at treating or ameliorating symptoms associated with an active herpes family type viral infection and also at reducing reoccurrences of symptoms associated with a latent herpes family type viral infection. Also disclosed is a process for obtaining the galactofucan sulfate from Undaria, wherein the process involves extracting plant material from Undaria in an acidic aqueous solution, at a temperature between 0-30°C, neutralising the extracted solution and separating out material with a molecular weight less than 10,000 Daltons.
Patent NZ-527351-A (NZ)
Title: Use of bisphosphonate for the treatment of osteonecrosis and for the management of patients at risk of developing ostenonecrosis
Inventor: LITTLE DAVID GRAHAM
IPC: A61K35/28
Filed: 2001-12-13
Abstract: A drug containing a bisphosphonate that may be suitable for the treatment of osteonecrosis and/or osteochondritis dissecans is disclosed, wherein the bisphosphonate is or selected from the group consisting of zoledronic acid, pamidronate, alendronate, etidronate, clodronate, risedronate, tiludronate, ibandronate, incadronate, minodronate, olpadronate, neridronate, EB-1053 or any pharmaceutically acceptable salt, hydrate or ester thereof. The drug may further be used to prevent the onset of osteonecrosis and/or osteochondritis dissecans and any complications associated with both diseases.
Patent NZ-537856-A (NZ)
Title: Method for determining the number of available transport seats in a computerized reservation system
Inventor: ARNAUD DENIS
IPC: G06Q10/00
Filed: 2003-06-13
Abstract: A process for determining the number of transport seats available in a computerized reservation system is disclosed. The system includes means for storing data on services that provide transport between two locations and their current reservation status, broken down by class of service, a process in which, at a predefined level of expected revenue, a number of seats locally available is determined. According to this process, for a given class of service on a given transport service, the following steps are carried out: (a) at least one other class of service of a transport service is selected, (b) the number of locally available seats is determined for the class of service of the transport service at the predefined level of expected revenue, and (c) an overall number of available seats is determined for the given class of service of the given transport service at the predefined level of expected revenue according to the different number of seats available locally.
Patent NZ-537866-A (NZ)
Title: Method for improving the loading capacity of tobacco
Inventor: FLEISCHHAUER HOLGER
IPC: A24B3/18
Filed: 2003-06-30
Abstract: Disclosed is a method for improving the loading capacity of tobacco, such as cut tobacco leaves or tobacco ribs and tobacco additives. The tobacco material containing between 10 and 30 % of initial humidity is treated with a treatment gas consisting of nitrogen and/or argon, at pressures of between 400 and 1,000 bar. The tobacco is then continuously decompressed and the discharged tobacco material is then thermally post-treated. The apparent density of the packed tobacco in the autoclaves is higher than 0.2 kg/dm³.
Patent NZ-538715-A (NZ)
Title: Protein kinase inhibitors and uses thereof
Inventor: COCHRAN JOHN
IPC: C07D403/12
Filed: 2003-08-12
Abstract: Disclosed are protein kinase inhibitors of formula I wherein: Ring B is a 6-membered aryl ring having 0-3 nitrogens; Z1 and Z2 are each independently selected from N or CH; T and Q are each independently selected from a saturated or unsaturated alkylidene chain wherein up to two methylene units of the chain are optionally and independently replaced as defined; and the remaining substituents are as defined in the specification. Compounds of the type disclosed are useful either alone or in combination with another pharmaceutically active agent for treating diseases associated with protein kinase activity.
Patent NZ-540879-A (NZ)
Title: Methods for treating taxol-induced sensory neuropathy
Inventor: SHELTON DAVID L
IPC: A61K39/395
Filed: 2003-12-23
Abstract: Disclosed Is the use of an anti-trkC agonist antibody in the manufacture of a medicament for treating Taxol-induced sensory neuropathy in an individual, wherein the medicament is formulated for administration before, during or after the administration of paclitaxel, docetaxel or another taxane to said individual.
Patent NZ-542133-A (NZ)
Title: Thick shrink film having high oxygen transmission rate
Inventor: WILBURN DANIEL S
IPC: B65D65/40
Filed: 2004-03-05
Abstract: A multilayer film that is particularly suited for the packaging of fresh seafood is disclosed, which comprises: (A) a first layer which is a first outer film layer and which serves as a heat seal layer, the first layer comprising a first polymer, the first layer having a thickness of from 2 to 20 percent of a total thickness of the multilayer film; and (B) at least one second layer which serves as a high oxygen transmission layer, the at least one second layer comprising at least one member selected from the group consisting of: (i) ethylene/butyl acrylate copolymer; (ii) homogeneous ethylene/alpha-olefin copolymer having a density of from 0.86 to 0.91 g/cc; (iii) heterogeneous ethylene/alpha-olefin copolymer having a density of from 0.89 to 0.91 g/cc; (iv) ethylene/methyl acrylate copolymer having a methyl acrylate mer content of from 20 to 24 mole percent; (v) ethylene/vinyl acetate copolymer having a vinyl acetate mer content of from 10 to 30 mole percent; (vi) styrene butadiene block copolymer; and the at least one second layer having a thickness of from 80 to 98 percent of the total thickness of the multilayer film; wherein the total thickness of the multilayer film being at least 1.5 mils (38 microns), and the film having an oxygen transmission rate of at least 10,000 cc/m2/24 hr at STP. The disclosure also pertains to a bag made from the film, as well as a packaged product utilizing the film.
Patent NZ-542693-A (NZ)
Title: Switching mechanism for a batch feed waste disposer
Inventor: BERGER THOMAS R
IPC: B02C23/04
Filed: 2004-03-09
Abstract: A switching mechanism for a food waste disposer is provided having a plastic one-piece housing that engages an external surface of the food waste disposer by snapping thereto. The switching mechanism also contains a switch capable of enabling operation of the food waste disposer in response to an interlock device positioned within the drain opening. Also provided is a method for converting a continuous feed waste disposer into a batch feed waste disposer. The switching mechanism includes a plug having a male end and a female end that can receive the electrical plug from the continuous feed waste disposer.
Patent NZ-543703-A (NZ)
Title: Frame fitting
Inventor: DAGG HAYDEN
Filed: 2005-11-18
Abstract: A fitting 10 for a building frame includes a sleeve 12 for mounting along a first member 14 and at least one flange 16, which is irremovably fastened to extend from the sleeve 12 and adapted for receiving and mounting a second member.
Patent NZ-546444-A (NZ)
Title: Phenyl derivatives as PPAR agonists
Inventor: ACKERMANN JEAN
IPC: C07D239/26
Filed: 2004-10-28
Abstract: Disclosed are compounds of Formula (I) wherein one of R5, R6 and R7 is (Formula II), and the remaining substituents are as defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof. Also disclosed are pharmaceutical compositions containing such compounds, a process for their preparation and their use for the treatment and/or prevention of diseases which are modulated by PPAR-delta and/or PPAR-alpha agonists.
Patent NZ-550138-A (NZ)
Title: Collapsible clothes drying rack with heated elements
Inventor: COSTELLO JASON MATTHEW
Filed: 2006-09-26
Abstract: A clothes drying rack includes clothes support members 106 provided with an internal heater, an electric heating element for example, and a collapsible support frame 130 that can be erected from the collapsed state, in which the rack can be conveniently stored or transported, into an A-frame configuration in which the clothes can be spread or hung on the support members to facilitate drying of the clothes.
Patent NZ-550476-A (NZ)
Title: Identification device for multilayer tubular structures
Inventor: BELLUM CLIFF
IPC: B31C3/00
Filed: 2005-04-01
Abstract: A multilayer tubular structure for products with an electronic detection device being embedded or interposed between two of the multiple layers of the tubular structure. The electronic detection device is responsive to radio frequencies and is able to store and transmit information about the multilayer tubular structure, the products, and processes that have been performed on same. A method is provided for manufacturing a multilayer tubular structure by embedding an electronic detection device between two of the multiple layers.